NZ307579A - Recombinant preduodenal lipases and polypeptides derivatives produced by plants, processes for obtaining them and their uses - Google Patents
Recombinant preduodenal lipases and polypeptides derivatives produced by plants, processes for obtaining them and their usesInfo
- Publication number
- NZ307579A NZ307579A NZ307579A NZ30757996A NZ307579A NZ 307579 A NZ307579 A NZ 307579A NZ 307579 A NZ307579 A NZ 307579A NZ 30757996 A NZ30757996 A NZ 30757996A NZ 307579 A NZ307579 A NZ 307579A
- Authority
- NZ
- New Zealand
- Prior art keywords
- plants
- recombinant
- obtaining
- processes
- derivatives produced
- Prior art date
Links
- 102000004882 Lipase Human genes 0.000 title abstract 4
- 108090001060 Lipase Proteins 0.000 title abstract 4
- 239000004367 Lipase Substances 0.000 title abstract 4
- 235000019421 lipase Nutrition 0.000 title abstract 4
- 229920001184 polypeptide Polymers 0.000 title abstract 3
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 3
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 3
- 239000002299 complementary DNA Substances 0.000 abstract 2
- 108091028043 Nucleic acid sequence Proteins 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 239000000419 plant extract Substances 0.000 abstract 1
- 230000001131 transforming effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/64—Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
- C12P7/6409—Fatty acids
- C12P7/6418—Fatty acids by hydrolysis of fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- C—CHEMISTRY; METALLURGY
- C10—PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
- C10L—FUELS NOT OTHERWISE PROVIDED FOR; NATURAL GAS; SYNTHETIC NATURAL GAS OBTAINED BY PROCESSES NOT COVERED BY SUBCLASSES C10G, C10K; LIQUEFIED PETROLEUM GAS; ADDING MATERIALS TO FUELS OR FIRES TO REDUCE SMOKE OR UNDESIRABLE DEPOSITS OR TO FACILITATE SOOT REMOVAL; FIRELIGHTERS
- C10L1/00—Liquid carbonaceous fuels
- C10L1/02—Liquid carbonaceous fuels essentially based on components consisting of carbon, hydrogen, and oxygen only
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
- C12N15/8243—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
- C12N15/8247—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine involving modified lipid metabolism, e.g. seed oil composition
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
- C12N9/18—Carboxylic ester hydrolases (3.1.1)
- C12N9/20—Triglyceride splitting, e.g. by means of lipase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/62—Carboxylic acid esters
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/64—Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
- C12P7/6436—Fatty acid esters
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/64—Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
- C12P7/6436—Fatty acid esters
- C12P7/6445—Glycerides
- C12P7/6454—Glycerides by esterification
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Biochemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Cell Biology (AREA)
- Nutrition Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Enzymes And Modification Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Plant Substances (AREA)
- Peptides Or Proteins (AREA)
Abstract
Recombinant nucleotide sequences containing cDNA coding for preduodenal lipase, or any sequence derived from this cDNA, is used for transforming plant cells to obtain recombinant preduodenal lipase of polypeptide derivatives. The transformed plants, or plant extracts, or recombinant preduodenal lipase or polypeptide derivatives may be useful for food or medicine.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9504754A FR2733249B1 (en) | 1995-04-20 | 1995-04-20 | RECOMBINANT DOG GASTRIC LIPASE AND POLYPEPTIDES DERIVED BY PLANTS, PROCESSES FOR OBTAINING SAME AND USES THEREOF |
PCT/FR1996/000606 WO1996033277A2 (en) | 1995-04-20 | 1996-04-19 | Recombinant preduodenal lipases and polypeptide derivatives produced by plants, processes for obtaining them and their uses |
Publications (1)
Publication Number | Publication Date |
---|---|
NZ307579A true NZ307579A (en) | 1999-11-29 |
Family
ID=9478306
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NZ307579A NZ307579A (en) | 1995-04-20 | 1996-04-19 | Recombinant preduodenal lipases and polypeptides derivatives produced by plants, processes for obtaining them and their uses |
Country Status (26)
Country | Link |
---|---|
US (2) | US6573431B1 (en) |
EP (1) | EP0822988B1 (en) |
JP (2) | JP4077875B2 (en) |
KR (1) | KR19990007901A (en) |
CN (1) | CN1185178A (en) |
AR (1) | AR004482A1 (en) |
AT (1) | ATE313632T1 (en) |
AU (1) | AU718905B2 (en) |
BG (1) | BG64320B1 (en) |
BR (1) | BR9608011A (en) |
CA (1) | CA2218418A1 (en) |
CZ (1) | CZ330997A3 (en) |
DE (1) | DE69635611T2 (en) |
ES (1) | ES2256858T3 (en) |
FR (1) | FR2733249B1 (en) |
HU (1) | HUP9801438A3 (en) |
IL (1) | IL117955A0 (en) |
MX (1) | MX9707973A (en) |
NZ (1) | NZ307579A (en) |
PL (1) | PL186586B1 (en) |
RU (1) | RU2235129C2 (en) |
SK (1) | SK140197A3 (en) |
TR (1) | TR199701207T1 (en) |
UA (1) | UA73267C2 (en) |
WO (1) | WO1996033277A2 (en) |
ZA (1) | ZA963146B (en) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2759857B1 (en) * | 1997-02-27 | 1999-04-30 | Biocem | NEW USES OF MALE STERILITY IN PLANTS |
FR2774379B1 (en) * | 1998-01-30 | 2002-03-29 | Groupe Limagrain Holding | PROCESS FOR THE PRODUCTION OF ALPHA 1-ANTITRYPSIN AND ITS VARIANTS BY PLANT CELLS, AND PRODUCTS CONTAINING THE ALPHA-ANTITRYPSIN OBTAINED THEREBY |
FR2777155B1 (en) | 1998-04-09 | 2000-06-23 | Meristem Therapeutics | SEEDS AND PLANTS OF WHICH THE GERMINATING POWER IS DESTROYED BY THE TOTAL OR PARTIAL ABSENCE OF AT LEAST ONE ENERGY RESERVE ESSENTIAL TO GERMINATION |
FR2810667B1 (en) * | 2000-06-23 | 2004-09-03 | Warner Lambert Co | PROCESS FOR ISOLATING AND PURIFYING PROTEIN, AND PROTEIN OBTAINED |
US7288124B2 (en) | 2004-09-08 | 2007-10-30 | L'oreal S.A. | Heteroaromatic binuclear black direct dyes |
US20110070201A1 (en) | 2005-07-18 | 2011-03-24 | Protalix Ltd. | Mucosal or enteral administration of biologically active macromolecules |
FR3036119B1 (en) * | 2015-05-15 | 2019-04-19 | Universite De Picardie Jules Verne | PROCESS FOR PRODUCING PROTEINS OF INTEREST FROM A PLANT STRUCTURE |
CN112480233B (en) * | 2020-12-14 | 2022-05-27 | 上海交通大学 | Bioactive peptide IAHPKLGKRIR, and preparation method and application thereof |
CN115669542B (en) * | 2022-11-04 | 2023-08-25 | 西北农林科技大学 | Plant tissue culture detoxification method |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3150988A1 (en) * | 1980-12-30 | 1982-08-05 | Institut Français du Pétrole, 92502 Rueil-Malmaison, Hauts-de-Seine | COMBUSTIBLE COMPOSITIONS CONTAINING ALCOHOLS AND FATTY ACID ESTERS AND IN PARTICULAR USE THAN DIESEL FUELS |
US5538868A (en) * | 1984-02-08 | 1996-07-23 | Cetus Oncology Corporation | Recombinant ricin toxin fragments |
GB8421210D0 (en) * | 1984-08-21 | 1984-09-26 | Celltech Ltd | Polypeptide and polypeptide composition |
GB2188057B (en) * | 1986-02-04 | 1990-03-07 | Inst Penyelidikan Minyak Kelap | Transesterification of fats and oils |
FR2603804B1 (en) * | 1986-09-17 | 1989-10-27 | Jouveinal Sa | LIPASES AND LIPASIC EXTRACTS, THEIR PREPARATION PROCESS AND THEIR APPLICATION IN THERAPEUTICS |
WO1991006661A1 (en) * | 1989-11-03 | 1991-05-16 | Opta Food Ingredients, Inc. | Lipase-catalyzed in situ generation of mono- and di-glycerides |
IL97645A (en) * | 1990-03-23 | 1997-03-18 | Gist Brocades Nv | Production of enzymes in seeds and their use |
DK162790D0 (en) * | 1990-07-06 | 1990-07-06 | Novo Nordisk As | PLANT CELL |
DK0596979T3 (en) * | 1991-08-01 | 2002-05-13 | Large Scale Biology Corp | Plant virus recombinant nucleic acids |
FR2683549B1 (en) * | 1991-11-13 | 1994-11-18 | Jouveinal Inst Rech | NUCLEIC ACIDS ENCODING FOR RABBIT GASTRIC LIPASE AND POLYPEPTIDE DERIVATIVES, THEIR USE IN THE PRODUCTION OF SUCH POLYPEPTIDES, AND PHARMACEUTICAL COMPOSITIONS BASED THEREON. |
FR2699179B1 (en) * | 1992-12-16 | 1995-01-06 | Jouveinal Inst Rech | Nucleic acids coding for dog gastric lipase and polypeptide derivatives, their use for the production of these polypeptides, and pharmaceutical compositions based thereon. |
IS4130A (en) * | 1993-03-01 | 1994-09-02 | Ab Astra | New polypeptide |
FR2722798B1 (en) * | 1994-07-25 | 1996-09-13 | Toulouse Inst Nat Polytech | 1PROCESS FOR THE PRODUCTION OF OLEAGINOUS FATTY ACIDS |
-
1995
- 1995-04-20 FR FR9504754A patent/FR2733249B1/en not_active Expired - Fee Related
-
1996
- 1996-04-18 IL IL11795596A patent/IL117955A0/en unknown
- 1996-04-19 AU AU56967/96A patent/AU718905B2/en not_active Ceased
- 1996-04-19 PL PL96322874A patent/PL186586B1/en not_active IP Right Cessation
- 1996-04-19 EP EP96915066A patent/EP0822988B1/en not_active Expired - Lifetime
- 1996-04-19 TR TR97/01207T patent/TR199701207T1/en unknown
- 1996-04-19 ES ES96915066T patent/ES2256858T3/en not_active Expired - Lifetime
- 1996-04-19 JP JP53152996A patent/JP4077875B2/en not_active Expired - Fee Related
- 1996-04-19 UA UA97115538A patent/UA73267C2/en unknown
- 1996-04-19 NZ NZ307579A patent/NZ307579A/en not_active IP Right Cessation
- 1996-04-19 RU RU97119046/13A patent/RU2235129C2/en not_active IP Right Cessation
- 1996-04-19 CA CA002218418A patent/CA2218418A1/en not_active Abandoned
- 1996-04-19 KR KR1019970707424A patent/KR19990007901A/en not_active Application Discontinuation
- 1996-04-19 DE DE69635611T patent/DE69635611T2/en not_active Expired - Lifetime
- 1996-04-19 SK SK1401-97A patent/SK140197A3/en unknown
- 1996-04-19 BR BR9608011A patent/BR9608011A/en not_active Application Discontinuation
- 1996-04-19 CZ CZ973309A patent/CZ330997A3/en unknown
- 1996-04-19 WO PCT/FR1996/000606 patent/WO1996033277A2/en not_active Application Discontinuation
- 1996-04-19 HU HU9801438A patent/HUP9801438A3/en unknown
- 1996-04-19 ZA ZA963146A patent/ZA963146B/en unknown
- 1996-04-19 AT AT96915066T patent/ATE313632T1/en not_active IP Right Cessation
- 1996-04-19 CN CN96194076A patent/CN1185178A/en active Pending
- 1996-04-22 AR ARP960102270A patent/AR004482A1/en unknown
-
1997
- 1997-10-10 BG BG101959A patent/BG64320B1/en unknown
- 1997-10-16 MX MX9707973A patent/MX9707973A/en not_active Application Discontinuation
-
1999
- 1999-07-02 US US09/348,930 patent/US6573431B1/en not_active Expired - Fee Related
-
2002
- 2002-09-17 US US10/245,405 patent/US20040072317A1/en not_active Abandoned
-
2007
- 2007-05-16 JP JP2007130029A patent/JP2007325590A/en active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU7659298A (en) | Recombinant lactoferrin, methods of production from plants and uses | |
HU9603170D0 (en) | Dna sequences coding for enzymes capable of facilitating the synthesis of linear alfa-1,4 glucans in plants, fungi and microorganisms | |
MY101972A (en) | Primate interleukin - 4 | |
DE10075019I2 (en) | New proteins with TNF inhibitory activity and their production. | |
IL111181A0 (en) | Stem cell proliferation factor, its preparation, purification and uses | |
NZ514025A (en) | Compositions and methods for the modification of gene transcription | |
IL195812A0 (en) | Human tslp dna and polypeptides | |
AU6929794A (en) | Regulation of plant growth | |
WO2000075350A3 (en) | Nucleic acid sequences encoding proteins involved in fatty acid beta-oxidation and methods of use | |
NZ307579A (en) | Recombinant preduodenal lipases and polypeptides derivatives produced by plants, processes for obtaining them and their uses | |
ATE113982T1 (en) | BRANCHING ENZYME AND ITS USE. | |
IL141869A0 (en) | Mammalian transforming growth factor beta-9 (ztgfss9) | |
HU895788D0 (en) | Process for producing peptides and medical products containing them | |
ATE182900T1 (en) | MUTATED FORM OF THE BETA-AMYLOID PRECURSOR PROTEINE GENE | |
GB9323225D0 (en) | Novel plant enzyme | |
ATA901196A (en) | USE OF ACTIVATED PROTEIN C FOR PRODUCING A PHARMACEUTICAL PREPARATION | |
WO1991011462A3 (en) | Merosin, nucleic acids encoding, fragments and uses thereof | |
CA2151381A1 (en) | Recombinant dog gastric lipase and pharmaceutical compositions | |
GB9517674D0 (en) | Plastid inner envelope membrane targeting polypeptides;manufacture and use thereof | |
AU7452187A (en) | New human lymphotoxin (TNF-beta) polypeptides their prepartion and use | |
DE3781832D1 (en) | C-TERMINAL-ALPHA-AMIDATING ENZYME AND METHOD FOR THE PRODUCTION AND USE THEREOF. | |
KR100256319B1 (en) | Stem cell proliferation factor | |
EP0290029A3 (en) | (19-alanine) calcitonin | |
UA22019A (en) | Method for determination of death-cup poison cytotoxicity |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RENW | Renewal (renewal fees accepted) | ||
ASS | Change of ownership |
Owner name: MERISTEM THERAPEUTICS SA, FR Free format text: OLD OWNER(S): PARKE-DAVIS |
|
RENW | Renewal (renewal fees accepted) | ||
RENW | Renewal (renewal fees accepted) | ||
EXPY | Patent expired |